Generic Biologics News
Most Popular Generic Biologics Story
Examining the generic biologics debate
With the healthcare reform debate heating up in Washington, lawmakers are focusing on the cost of biotech drugs now more than ever before. Drug prices make up only 10 percent of healthcare costs in Read more...
Latest Headlines
- February 1, 2011
- January 20, 2010
- January 19, 2010
- January 15, 2010
- November 30, 2009
- October 30, 2009
- July 24, 2009
- July 22, 2009
- July 15, 2009
- June 26, 2009
- June 10, 2009
- December 5, 2008
- April 24, 2008
- August 31, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
